SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-21-044718
Filing Date
2021-11-16
Accepted
2021-11-16 07:56:41
Documents
2
Period of Report
2021-11-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 6508
2 EX-24 DOCUMENT attachment1.htm EX-24 4455
  Complete submission text file 0000899243-21-044718.txt   12397
Mailing Address 550 HILLS DRIVE BEDMINSTER NJ 07921
Business Address
GEMAYEL GEORGES (Reporting) CIK: 0001256088 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39438 | Film No.: 211414147

Mailing Address 300 ONE KENDALL SQUARE, 3RD FLOOR CAMBRIDGE MA 02139
Business Address 300 ONE KENDALL SQUARE, 3RD FLOOR CAMBRIDGE MA 02139 (617) 401-4400
Gemini Therapeutics, Inc. /DE (Issuer) CIK: 0001816736 (see all company filings)

IRS No.: 851613057 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations